Saltar al contenido
OECDReferencia EN/AU/PS1090777

Enhanced Enlite Sensor (MMT-7008) and Guardian Sensor 3 (MMT- 7020) Glucose Monitoring System

Información oficial organizada para facilitar su consulta. La publicación de la fuente conserva la autoridad.

Identificación

Identificación del producto

Producto
Enhanced Enlite Sensor (MMT-7008) and Guardian Sensor 3 (MMT- 7020) Glucose Monitoring System

Información oficial

Riesgo y medidas

Riesgo o peligro
The sensors may show falsely elevated sensor glucose readings for users who are taking hydroxyurea, an anti-neoplastic drug, used primarily in chemotherapy. Incorrect glucose readings may result in incorrect diabetes treatment decisions. If incorrect information is used to make treatment decisions, this could lead to an incorrect dose of insulin. Hydroxurea use results in higher sensor glucose readings compared to blood glucose readings and may result in the following: · Inaccurate graphs or missed alarms and alerts · Delay to or loss of sensor-enabled insulin suspension (sensor-enabled insulin pump use only) · Sensor glucose readings in CareLink reports being substantially higher than blood glucose readings
Recomendaciones
Medtronic will contact affected users in writing. Medtronic are advising patients: · Do not use continuous glucose monitoring while taking hydroxyurea. · Only use the blood glucose meter to monitor glucose levels while taking hydroxyurea. · Consult with a healthcare professional if users are taking hydroxyurea and using continuous glucose monitoring. · When using an insulin pump system, disable the continuous glucose monitoring feature by going to the sensor settings. Refer to the user guide that came with the insulin pump for instructions. · Always check the label of any medication to confirm with a healthcare professional whether hydroxyurea or hydroxycarbamide is an active ingredient. For further information, contact Medtronic Customer Service by phone on 1800 777 808.

Información oficial

Operadores económicos

Fabricante
Medtronic Australasia Pty Ltd

Territorio

Geografía

Distribución
Retirada en Australia
País de retirada
Australia

Procedencia y contexto

NagameAlert distingue el contenido publicado por la fuente de su organización y normalización. Los valores marcados como «NagameAlert» pertenecen a esa capa de tratamiento. Comprueba siempre medidas, alcance y actualizaciones en la publicación oficial.